NEW YORK, July 24, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of PepGen Inc. (NASDAQ: PEPG). Shareholders who purchased shares of PEPG during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/pepgen-inc-loss-submission-form/?id=157782&from=3 CLASS PERIOD: March 7, 2024 to March ...

NEW YORK, July 24, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of PepGen Inc. (NASDAQ: PEPG).Shareholders who purchased shares of PEPG during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/pepgen-inc-loss-submission-form/?id=157763&from=4CLASS PERIOD: March 7, 2024 to March 3, 2025 ...

公司事件 - 股东在2024年3月7日至2025年3月3日期间购买PepGen Inc (NASDAQ: PEPG)股票可能因公司虚假陈述或隐瞒信息而遭受损失 [3] - 公司被指控在关键产品PGN-EDO51的疗效和安全性方面误导投资者 且CONNECT2二期研究存在缺陷 可能影响FDA批准 [3] - 由于上述问题 公司可能暂停CONNECT2研究 导致PGN-EDO51的临床前景和商业化预期被高估 [3] 法律程序 - 股东需在2025年8月8日前登记参与集体诉讼 注册后可通过监测软件获取案件进展 [4] - 律所提供免费代理服务 旨在追究企业因虚假陈述导致股价虚高的责任 [5] 联系方式 - 股东可通过指定链接提交损失申报表 或联系Gross Law Firm纽约办公室 [2][6]

ATLANTA, July 21, 2025 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against PepGen Inc. (“PepGen” or the “Company”) (NASDAQ: PEPG). The lawsuit alleges that Defendants made materially false and/or misleading statements and/or failed to disclose material adverse information about PepGen’s business, operations, and prospects, including allegations that: (i) PGN-EDO51 was less effective and safe than Defendants had led investors to believe; (ii) the CONNECT2 study was deficient for pur ...

集体诉讼案件 - 罗森律师事务所提醒在2024年3月7日至2025年3月3日期间购买PepGen证券的投资者注意2025年8月8日的首席原告截止日期 [1] - 投资者可能有权通过应急费用安排获得补偿而无需支付任何自付费用 [1] - 集体诉讼已经提起，首席原告需在2025年8月8日前向法院提出申请 [2] 罗森律师事务所背景 - 罗森律师事务所在全球范围内代表投资者，专注于证券集体诉讼和股东衍生诉讼 [3] - 该事务所曾创下针对中国公司的最大证券集体诉讼和解记录 [3] - 2017年被ISS证券集体诉讼服务评为证券集体诉讼和解数量第一名 [3] - 自2013年以来每年排名前四，已为投资者追回数亿美元 [3] - 2019年单独为投资者获得超过4.38亿美元赔偿 [3] 案件详情 - 指控被告在整个集体诉讼期间作出虚假和误导性陈述或未能披露 [4] - PGN-EDO51的有效性和安全性低于被告向投资者传达的水平 [4] - CONNECT2研究对于FDA批准存在危险或缺陷 [4] - 由于上述原因，PepGen可能停止CONNECT2研究，PGN-ED051的临床、监管和商业前景被夸大 [4] - 被告的公开声明在所有相关时间都存在重大虚假和误导性 [4] 投资者参与方式 - 投资者可通过网站、电话或电子邮件加入PepGen集体诉讼 [2][5] - 在集体认证前，投资者可选择自己的律师或保持缺席 [6] - 投资者分享未来潜在赔偿的能力不取决于是否担任首席原告 [6]

NEW YORK, July 17, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in PepGen Inc. ("PepGen Inc." or the "Company") (NASDAQ: PEPG) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of PepGen Inc. investors who were adversely affected by alleged securities fraud between March 7, 2024 and March 3, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/pepgen-inc-lawsuit-submissio ...

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In PepGen (PEPG) To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in PepGen between March 7, 2024 and March 3, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648. NEW YORK, July 16, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder ri ...

NEW YORK, July 15, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of PepGen Inc. (NASDAQ: PEPG) between March 7, 2024 and March 3, 2025, both dates inclusive (the “Class Period”), of the important August 8, 2025 lead plaintiff deadline. SO WHAT: If you purchased PepGen securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NE ...

集体诉讼案件 - 针对PepGen Inc投资者提起集体诉讼 指控公司在2024年3月7日至2025年3月3日期间涉嫌证券欺诈 [1] - 诉讼旨在为受影响的投资者挽回损失 相关投资者需在2025年8月8日前申请成为首席原告 [3] 指控内容 - 公司主打产品PGN-EDO51的有效性和安全性低于公司向投资者传达的水平 [2] - 公司第二阶段CONNECT2研究存在安全隐患 可能不符合FDA批准要求 [2] - 由于上述问题 公司可能暂停CONNECT2研究 且PGN-EDO51的临床、监管和商业前景被夸大 [2] - 公司公开声明在相关时间段内存在重大虚假和误导性内容 [2] 律所背景 - Levi & Korsinsky律所过去20年为受损股东追回数亿美元赔偿 [4] - 该律所在证券集体诉讼领域具有丰富经验 拥有70多名员工的专业团队 [4] - 连续七年被ISS证券集体诉讼服务评为美国顶级证券诉讼律所之一 [4]

诉讼案件概述 - 律师事务所Levi & Korsinsky针对PepGen Inc (NASDAQ: PEPG)发起证券集体诉讼 旨在为2024年3月7日至2025年3月3日期间因涉嫌证券欺诈受损失的投资者追偿 [1] - 诉讼提交截止日期为2025年8月8日 投资者可申请成为首席原告但非强制要求 [3] 指控内容 - 公司被指控虚假陈述及隐瞒信息 包括核心产品PGN-EDO51的疗效与安全性低于宣称水平 [2] - 第二阶段CONNECT2研究存在安全隐患 可能不符合FDA审批标准 [2] - 上述问题导致CONNECT2研究可能中止 PGN-EDO51的临床、监管及商业前景被夸大 [2] 律所背景 - Levi & Korsinsky过去20年累计为股东追回数亿美元赔偿 拥有70人专业团队 [4] - 连续七年被ISS证券集体诉讼服务评为全美前50大证券诉讼律所 [4]